Traton SE (TRATF)

Sage Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,266	2,542	1,730	1,439	2,002	1,714
Short-Term Investments	13	14	53	73	226	2,105
Cash & Short-Term Investments	2,279	2,556	1,783	1,512	2,228	3,819
Cash Growth	22.59%	43.35%	17.92%	-32.14%	-41.66%	-24.09%
Accounts Receivable	10,351	9,990	9,448	8,409	6,539	4,863
Other Receivables	2,059	1,869	1,506	1,493	1,428	937
Receivables	12,410	11,859	10,954	9,902	7,967	5,800
Inventory	8,085	7,529	7,444	6,574	5,454	4,325
Other Current Assets	928	825	917	697	579	454
Total Current Assets	23,764	22,804	21,101	19,106	16,230	14,398
Property, Plant & Equipment	14,602	12,934	13,235	13,208	13,586	12,432
Long-Term Investments	1,827	1,780	1,717	1,532	1,940	1,452
Goodwill	5,866	6,154	6,083	6,184	6,173	3,305
Other Intangible Assets	7,362	3,626	3,741	4,084	4,252	1,124
Long-Term Accounts Receivable	9,444	9,090	7,767	6,560	5,834	4,783
Long-Term Deferred Tax Assets	2,551	2,604	2,366	2,274	2,147	1,231
Long-Term Deferred Charges	-	3,763	3,373	3,111	2,921	2,337
Other Long-Term Assets	1,035	2,792	2,316	2,197	2,038	1,705
Total Assets	66,451	65,547	61,699	58,256	55,121	42,767
Accounts Payable	6,053	5,349	5,791	5,518	4,245	2,769
Accrued Expenses	-	111	98	-	-	-
Current Portion of Long-Term Debt	10,525	2,263	2,421	4,906	1,983	2,592
Current Portion of Leases	-	254	239	240	241	192
Current Income Taxes Payable	300	411	242	250	200	139
Other Current Liabilities	8,740	8,872	8,578	8,197	9,378	6,163
Total Current Liabilities	25,618	23,260	22,369	22,632	19,847	15,455
Long-Term Debt	14,204	5,994	6,175	4,611	6,663	203
Long-Term Leases	1,149	917	941	968	996	856
Long-Term Deferred Tax Liabilities	654	672	681	690	804	767
Other Long-Term Liabilities	5,700	5,851	6,098	6,195	6,116	5,589
Total Liabilities	49,127	47,703	45,211	43,882	41,674	29,598
Common Stock	500	500	500	500	500	500
Retained Earnings	7,938	8,135	5,464	2,964	1,477	-4,479
Comprehensive Income & Other	8,881	9,203	10,518	10,904	11,467	16,918
Total Common Equity	17,319	17,838	16,482	14,368	13,444	12,939
Minority Interest	5	6	6	6	3	230
Shareholders' Equity	17,324	17,844	16,488	14,374	13,447	13,169
Total Liabilities & Equity	66,451	65,547	61,699	58,256	55,121	42,767
Total Debt	25,878	24,528	21,876	21,225	18,283	12,343
Net Cash (Debt)	-23,599	-21,972	-20,093	-19,713	-16,055	-8,524
Net Cash Per Share	-47.20	-43.94	-40.19	-39.43	-32.11	-17.05
Filing Date Shares Outstanding	498.92	500	500	500	500	500
Total Common Shares Outstanding	498.92	500	500	500	500	500
Working Capital	-1,854	-456	-1,268	-3,526	-3,617	-1,057
Book Value Per Share	34.71	35.68	32.96	28.74	26.89	25.88
Tangible Book Value	4,091	8,058	6,658	4,100	3,019	8,510
Tangible Book Value Per Share	8.20	16.12	13.32	8.20	6.04	17.02
Land	-	6,733	6,438	5,936	5,593	5,018
Machinery	-	9,639	9,124	8,375	7,722	7,293
Order Backlog	-	-	-	28,552	-	-

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.